Clinical Trial Update: Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intravenous ascorbic acid to reduce intraoperative blood loss in women with uterine leiomyoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Leiomyoma

Drugs mentioned

• Intravenous ascorbic acid (ascorbic acid)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Uterine Leiomyoma | Phase 3 | Status: COMPLETED